Tim Cools joins us on Psychedelics Today to talk about his project, Psychedelic Experience, a web platform that allows individuals to post reviews about different psychedelic retreat centers and organizations. There is a psychedelic journal feature that is currently in beta-testing that allows users to write about their experiences, in hopes to further phenomenological and qualitative research in the future. As described on the site, this is a “one-stop-shop” for resources surrounding psychedelics.
About Psychedelic Experience
We aim to reduce harm and stigma associated with psychedelics by helping to best inform users, offer tools to help with integration of their experiences, and a space for communal support.
One-stop-shop web resource surrounding psychedelics
Online community by and for beginning and experienced psychonauts.
Promote safe use of psychedelics by providing scientific, responsible information.
Privacy is a top-priority. Users have full control over what is public and what isn’t.
Psychedelic experiences journal
Keep a private journal of your psychedelic experiences.
Share your experiences with your friends or the community. Reports are peer-reviewed by community to ensure quality.
Integrate your experiences by discussing them with fellow psychonauts and professional therapists.
Advanced search functionality by substance and keywords. Anonymous statistics can beused for scientific research.
Global organisations directory
A community managed global directory of organisations related to psychedelic experiences.
Connect people with honest organisations to stay updated on meetings, events and retreats.
Collect reviews by the community to create an unbiased image of the organisations.
Promote sustainable projects to help indigenous communities.
Issue warnings for organisations linked to abuse or dishonesty.
Tim lives in Belgium as a professional software developer/social entrepreneur. With his latest project, PsychedelicExperience.net, he aims to reduce harm and stigma associated with the use of psychedelics, and to support psychedelic research. Driven by some profound experiences, he hopes to make psychedelics more accessible in a safe way.
Nicholas Powers Ph.D. is a poet, journalist, and Associate Professor of English, SUNY Old Westbury. Nick joins us to talk about psychedelics, race, cultural diversity, and the future of psychedelics. Race and diversity within the psychedelic community has been a hot topic lately, and it is an important topic to continue discussing and examining. Unfortunately, the community is exclusive to people of privilege and power, which shows some concern when it comes to the future direction of this field, as it leaves out diverse ideas and beliefs from people from other cultural backgrounds and communities.
What are your thoughts on this topic? Leave us a comment below!
Show Topics
Diversity in research
Monica Williams – Diversity in the psychedelic research
The trust between diverse populations and institutional research
History of forced sterilizations and the Tuskegee syphilis study
The importance of storytelling and authentically listening to stories of people from other cultural backgrounds
Start your own psychedelic community
Psychedelics and intergenerational trauma
Including minority groups into the psychedelic community
Nicholas Powers is a poet, journalist and professor. His books, The Ground Below Zero and Theater of War, was published by Upset Press. He has written for The Indypendent, Alternet and The Village Voice. He has spoken and read all over the country. He teaches literature at SUNY Old Westbury and co-hosts the long running New York City College Poetry Slam at the Nuyorican Cafe. If you would like to work with Nick, please contact tara@upsetpress.org.
Dr. Scott Shannon joins Psychedelics Today to share his experience and insights about ketamine therapy used in conjunction with integrative psychiatry. Dr. Shannon has been working with ketamine for the past year within his psychiatry practice and has found tremendous benefit in using this medicine for particular disorders. Dr. Shannon is also part of the Fort Collins MAPS MDMA-assisted psychotherapy Phase 3 study, which is just starting up.
Show Topics/Notes
What is ketamine?
Mechanisms of action of ketamine.
What is the ketamine experience like?
Three types of administration methods – IV, IM, and oral
MDMA-assisted psychotherapy and the MAPS Phase 3 trials
Transpersonal experiences fostering change and transformation
Critiques of traditional psychiatry.
Patient with 40 years of depression became a new person no longer suffering from depression.
Electro Convulsive Therapy was almost an option, thankfully avoided.
The importance of music with ketamine therapy and other psychedelics
Scott Shannon: Cannabidiol in the Treatment of Anxiety
I decided to become a psychiatrist in high school after my first psychology class. The amazing capacity of the human mind simply astounded me. I wanted to help people by using this power of the mind. What intrigued me the most then (and now) is that our human potential remains only partially understood. I am still on that journey of discovery about our true potential. To this end, I resonate with the theme of empowerment: my greatest day is the day that you have the skills to thrive without my services.
I feel blessed with all that I have been given in my life. I have been married for almost thirty years to Suze with two wonderful children, Noah and Sarah. I love to travel the world teaching or just exploring. My nature is relentlessly creative and curious. I love to cycle, snowboard, golf, run, climb, backpack and listen to music. Seamus, my big black Lab, may accidentally show up to work with me occasionally just because he likes people so much. My spiritual life is very important to me and I have meditated for over thirty years. Helping people makes my heart sing.
As a child and adolescent psychiatrist, my current focus involves supporting young people to find wholeness and recover their full health in body, mind and spirit. Although I use prescription medication at times, I much prefer to employ natural methods like nutrition, supplements, mind-body skills, acupuncture and a shift in awareness to support the healing process. This approach represents the new field of Integrative Psychiatry. Most importantly, I employ a holistic philosophy to understand people and their struggles. The single most important thing that I have learned in my professional life is to listen well: deeply and intuitively. After this listening, much of my work involves teaching you what I have heard. I founded Wholeness Center to work in collaboration with a team of gifted healers to help you better understand your story.
College: University of Arizona
Medical School: University of Arizona
Internship: Columbia Program, Cooperstown, NY
Psychiatric Residency: Columbia Program, Cooperstown, NY
Child/Adolescent Psychiatry Fellowship: University of New Mexico
If you liked this episode you may also like these episodes
Kyle and Joe report from the scene of the amazing Horizons: Perspectives on Psychedelics conference. We had the chance to interview attendees of Horizons NYC 2017 outside the venue on the closing day.
Horizons is a fantastic event at an amazing venue in the heart of Manhattan at the historic venue – “The Cooper Union.” The same podium on stage was shared by Abraham Lincoln, Susan B Anthony, and along with many other important historical figures.
It was an amazing event and we hope that this episode helps share some of the excitement. We talked to past guests, future guests, and also some new friends. You may recognize some of the voices 🙂 Let us know what you think of this episode and if you want to hear similar episodes to this in the future.
In the show, we speak about a lot of things from Horizons NYC including
The most interesting thing learned
The sense of community inside a conference like this
Some problems the movement has that we need to stay aware of
Issues with communicating the science of psychedelics with a wider audience
Volunteering for events for free tickets
Do you want to listen to Joe and Kyle recap their highlights of the conference and the Psymposia Microdosing event? Support us on Patreon to get exclusive access! Check out the video introduction to this episode – Here
Horizons: Perspectives on Psychedelics is an annual forum that examines the role of psychedelic drugs in science, medicine, culture, and spirituality.
In recent years, a growing community of scientists, doctors, artists, activists, seekers, and scholars have orchestrated a renaissance in psychedelic thought and practice.
Horizons brings together the brightest minds and the boldest voices of this movement to share their research, insights, and dreams for the future.
Horizons was founded in 2007 by Kevin Balktick, with Neal M. Goldsmith, Ph.D., joining as speaker curator and MC in 2008.
Horizons Media, Inc., a 501c(3) not-for-profit educational charity, is currently led by board members Kevin Balktick, Neal M. Goldsmith, Ph.D., James Vasile, Esq., and Ingmar Gorman, M.A.
Having outgrown Judson Memorial Church, its original location, Horizons is now hosted at The Cooper Union Great Hall, which has been a center for public dialogue since its founding in 1858, having hosted such illustrious speakers as Abraham Lincoln, Mark Twain, Frederick Douglass, Susan B. Anthony, and more recently, Barack Obama.
Horizons Media, Inc. conducts no other business besides the annual conference and is funded in solely by registration and concession sales. All profits go towards producing and improving the following year’s event. Its board members are not compensated.
Horizons Media, Inc. is not a political advocacy or scientific research organization, nor does it have any financial relationships with other organizations and businesses that participate as presenters or informational presences.
Sign up for our online course, “Navigating Psychedelics: Lessons on Self-Care & Integration”
Download
Animals are known to indulge in psychoactive compounds. Humans are not the only species who like to become intoxicated. From bees drinking to fermented nectars to reindeer of the Siberian tundra eating Amanita muscaria mushrooms, Aaron and Andras find a creative way to start a conversation about drug policy, harm reduction, and psychedelics. Aaron and Andras have started a company that produces tshirts depicting cute animals doing drugs. While this may seem like a way to promote drug use using cute animals, Aaron and Andras have a deeper meaning, which is about starting a conversation and trying to shift the cultural narrative about drug use.
If you want to get one of your own t-shirts, use the coupon code: PSYCHEDELICSTODAY25 to receive 25% off your purchase!
Cute Animals Doing Drugs was created by two friends to raise awareness around these issues, support drug policy reform, and encourage honest conversations about drugs in everyday life.
We believe individuals have the right to sovereignty over their own consciousness and that there is no reason to deny any adult the safe and beneficial use of psychoactive substances.
We believe social and political change can start from the bottom-up. Our apparel serves as a conversation-starter and a fun, unique way to show your support for an increasingly important social issue.
Cute Animals Doing Drugs is here to call attention to these issues, support psychedelic research, encourage drug policy reform, and promote cognitive liberty for all.
We also donate 10% of our pre-tax profits to MAPS, the Drug Policy Alliance, and other drug-related non-profit organizations.
Andras L is a cofounder of Cute Animals Doing Drugs Apparel, an initiative intended to help shift societal perceptions around drug use. Cute Animals builds on his previous work as a director on the board of Canadian Students for Sensible Drug Policy, where he advocated for the advancement of harm reduction and evidence-based drug policy reform. He is especially focused on reversing harmful policies and combating stigma. Andras graduated with an M.Sc. in Primary Care Research from McGill University and now researches infectious disease.
Aaron
Aaron co-founded Cute Animals Doing Drugs Apparel with Andras in the summer of 2017. He finished his BA at McGill University in 2014 and has since been traveling the world and working online. Aaron has a longstanding fascination with psychedelics, and is particularly interested in the subjective elements of psychedelics experience as well as the potential broad social impact of mainstreaming psychedelic use, especially in spiritual contexts. He writes about personal development, spirituality, and psychedelic experience at freedomandfulfilment.com.
Download Sara Gael joins us on this week’s episode. Sara is the Director of Harm Reduction at the Zendo Project. We get into some great stuff including some of Zendo’s biggest wins, how Zendo works, how to discuss harm reduction with festival organizers, and how to manage difficult experiences that arise in the Zendo. Something interesting that we learned during this talk was how law enforcement at Burning Man has really been interested in learning more about Zendo and their services, and requested Zendo to help train their staff.
Sara also shares her experience and insights working on the MAPS Phase 2 MDMA-assisted psychotherapy for PTSD trials and how she got involved in psychedelic research. We also explore how transpersonal psychology can serve as an important framework for working with psychedelic experiences.
We hope you enjoy this episode. Be sure to leave us a comment below and share this episode!
The Zendo Project
The Zendo Project is sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). Zendo provides harm reduction services to the community and to festivals. Zendo strives to:
Reduce the number of psychiatric hospitalizations and arrests.
Create an environment where volunteers can work alongside one another to improve their harm reduction skills and receive training and feedback.
Demonstrates that safe, productive psychedelic experiences are possible without the need for law enforcement-based prohibitionist policies.
Sara Gael, M.A., Director of Harm Reduction, Zendo Project
Sara received her Master’s degree in Transpersonal Counseling Psychology at Naropa University. She began working with MAPS in 2012, coordinating psychedelic harm reduction services at festivals and events worldwide with the Zendo Project. Sara was an Intern Therapist for the recently completed MAPS Phase 2 clinical trial of MDMA-assisted psychotherapy for PTSD in Boulder, CO. She maintains a private practice as a psychotherapist specializing in trauma and non-ordinary states of consciousness. Sara believes that developing a comprehensive understanding of psychedelic medicines through research and education is essential for the health and well being of individuals, communities, and the planet.
Community is an important part of integration. One of the most difficult aspects of integration is returning to a society that doesn’t understand or support psychedelic exploration. In fact, re-entering society can feel like a stark contrast between the interconnected, transpersonal state of the psychedelic experience. Therefore, one of most important tools for successful integration is a supportive, understanding community. We encourage our Guests to connect with and build supportive communities around themselves when they return home from the event. We support them in seeking professional help if necessary.
In this episode, Kyle and Joe talk with Julie Megler from Entheogenic Research, Integration, and Education (ERIE) about psychedelics and integration. We learn about the work and mission of ERIE, and how Julie got involved/interested in psychedelics. Integration is a growing concern in the psychedelic world. We continue the conversation by having Julie on the show to learn more about her work. Leave us a comment below and let us know what you think!
ERIE is a 501(c)(3) organization dedicated to the sharing of entheogenic and transpersonal knowledge in a non-hierarchical, community based format, located in the San Francisco Bay Area.
We offer a platform for entheogenic research, integration and education. ERIE is not only a hub of integration information for entheogenic and transpersonal experiences, we also host peer integration circles to facilitate meaning-making and community building. We host monthly educational events including symposiums, forums, and conferences on varied topics surrounding entheogenic research and activism.
We are dedicated to supporting cognitive liberty by offering a learning environment to support grassroots education and outreach on the topics of integration and entheogenic potentials.
Mission
The Entheogenic Research, Integration, and Education (ERIE) mission:
1) Review and conduct research on the use of traditional plant medicines, and their modern analogs, for creativity, healing, personal growth, and spiritual exploration
2) Develop integration methods that combine new research with existing, tested practices to help people incorporate extraordinary experiences into their lives
3) Articulate a new educational paradigm that honors and draws upon the vast Indigenous knowledge of plant and fungi kingdoms, then envisions new applications of it within contemporary Western contexts
4) Create a forum for the responsible discussion of these topics.
*Psychiatric Nurse Practitioner * Trained in Somatic Experiencing * Shipibo/Vegetalista Dieta Experience*
Julie is a board certified nurse practitioner in psychiatry and family medicine. She received her Master’s of Science in Nursing from the University of Miami, Florida and post master’s certificate in psychiatry at the University of California-San Francisco. Julie maintains licenses in family medicine and psychiatry in an effort to close the gap between medical and psychiatric care, incorporating the mind/body connection for most effective treatment. She currently is in private practice in the San Francisco/Bay Area.
Her practice focuses on integrative mental health services for emotional and physical well being, as well as integration of non-ordinary states of consciousness. In addition to her clinical work, Julie is on the board of directors of ERIE (Entheogenic Research, Integration, and Education). She has presented on the topics of psychedelic risk reduction, integration, and therapeutic applications of ayahuasca at the Psychedelic Science Conference 2013 & 2017, The Women’s Visionary Congress, Detroit’s First Entheogenic Conference, and the Visionary Convergence 2015.
She has also co-authored chapters in the books Manifesting Minds and The Therapeutic Uses of Ayahuasca. As an experienced clinician, and activist for the psychedelic movement, Julie is dedicated to educating the community about safety and the therapeutic benefits of entheogens. Her particular emphasis on integration assists individuals to develop practices that bring insights from entheogenic work to daily life. You can learn more about Julie’s work at erievision.org & mindfulnp.com.
Julie has done many ayahuasca sessions and other plant work as well. This along with her medical provider practice as a nurse practitioner in the San Francisco Bay Area. She is able to speak about psychedelic integration from a unique perspective with her background. We think you will really enjoy this episode and please let us know what you think.
We discuss our recent trip to MAPS‘s Psychedelic Science 2017. It was incredibly fun and we loved being able to connect with so many with this shared interest. Many attendees are actively working to progress the case of psychedelic substances.
This was the largest psychedelic conference ever in recorded history attended by over 3000 people from 42 countries. There were discussions around ayahuasca, peyote, DMT, salvia, MDMA and many other substances. Some of the most interesting discussions were around ibogaine treating people with addiction. Turns out there are far more things that can be treated with ibogaine than simply opiate addiction.
I was very excited to discuss drug testing and harm reduction with the people from DanceSafe. We were also able to check out some really interesting technology – lights and music – that triggered some of the most intense visuals of my life. Illuminated SF put that demonstration together. It is highly recommend.
The experience of Psychedelic Science 17 was so incredible and encouraging that I cannot wait to go to the next one. Being around the movement was truly humbling and gratifying. Connecting with people from as far as Brussels, Poland and Hong Kong gave extra context to how far and wide this movement is spreading and that there is real depth in the movement.
We hope you enjoy the episode. If you want to connect with us please feel free to reach out using the contact page. If you want to stay in touch with us please join our mailing list and we will send some interesting links to you on a semi regular basis.
Links
https://www.solarwolfenergy.com/
https://maps.org
MAPS made available a tremendous amount of the talks for free on youtube. You should spend some time digging through the talks for things you may find very interesting.
Download Kevin is a science writer, graduate student researcher and aspiring clinician, harm reduction educator and substance use recovery advocate. Kyle and Joe talk to him about loads of topics including early Iboga therapies, an early Boston Ibogaine Conference, his approach to journalism and his future aspirations to do future clinical work and research.
Kevin graduated from Northeastern University in 2013 with a degree in neuroscience. As an undergraduate he completed an internship as a research assistant at Harvard Medical School working on the Phase 2 dose-response study investigating the therapeutic potential of MDMA-assisted psychotherapy for treatment of cancer related anxiety. Kevin was also one of the founders of the Northeastern chapter of Students for Sensible Drug Policy, and in 2009 the group hosted and co-sponsored the Boston Ibogaine Forum. He now lives in New York City where he is enrolled in a clinical psychology graduate program at The New School for Social Research and is pursuing a doctoral degree. Kevin has worked part-time for the Drug Policy Alliance, and also works as a writer covering topics related to psychedelic therapy, addiction, and mental health advocacy. His recent contributions include: New Scientist, Reason.com, Reset.me, Reality Sandwich, and VICE.com.
“Through my lens, so many problems in this world are driven by people acting from a reactionary place of fear and pain instead of from a place of compassion or love.” – Natalie Ginsberg
Joe and Kyle spoke with Natalie Ginsberg, Policy and Advocacy Manager at Multidisciplinary Association for Psychedelic Studies (MAPS). Natalie provides us with a summary on facets of the current state of global drug policy. She also discusses the role of racism and privilege in the psychedelic community in America. The following is an excerpt from our interview.
Edited by: Alyssa Gursky
Natalie: This past year, the UN General Assembly met for the first time in 20 years to revisit international drug treaties. A special session was called on the world drug problem. There were a series of different meetings. Vienna hosts something called the, Commission on Narcotic Drugs, every year. First, there is a big gathering in Vienna where reformers, non-reformers, and people working both from civil society on drug policy come to meet with delegates from around the world and educate them.
They tried to move drug policy from a criminalization approach to a more public health and harm reduction kind of approach.That was also pretty inspiring, and it was definitely a bit frustrating in terms of progress.We would’ve liked the outcome document to reflect much more progressive drug policy stances, but they’re very influenced by countries like Russia and China, who are really not open to the harm reduction approaches at all.
Being there, you meet so many global representatives. For example, the so-called drug czar, but he doesn’t like that name. The National Drug Coordinator of Czech Republic, for example, is really supportive of psychedelic advocacy and was able to host a lot of more innovative, progressive events. The Colombian health minister gave a really powerful speech on the floor of the United Nations (UN), basically saying the drug war… using that Einstein quote, “The definition of insanity is doing the same thing and expecting different results.” It was really epic for the minister from Columbia to be saying that to the whole UN.
Overall, for me, what was so, so valuable was really this coming together of the international reform community. Now, I work super-closely with advocates from Afghanistan, Mexico, and Nigeria. We’re much more in the same loop of what’s going on and learning about how we’re doing work in different countries is important because the UN is a really slow body that is quite reactionary, and it’s really driven forward by individual countries’ progress. The more we can support individual countries moving forward, the better chance we have for them to kind of influence the UN later.
Joe: Are there any star countries that you noticed that are really doing stuff that might not be on the radar yet?
Natalie: Bolivia actually legalized coca leaves and has done some really important work around protecting cultural indigenous plant medicines, like promoting the traditional use of these substances.
As I mentioned, the Czech Republic is really, I’d say, the leader on all things psychedelic that are not traditional, indigenous use. I would also say that even though Portugal gets a lot of attention for decriminalizing drugs, they actually weren’t the first place to do that. The Czech Republic has been decriminalizing drugs longer than Portugal, as has Spain. Portugal received a great deal of attention because they did it in response to a big opiate crisis. There’s some incredible results to show how dramatically things have shifted, but other countries have kind of taken that stance for a while, so there isn’t as much of a shift. But, they do have really promising results from not having a crazy drug war.
Spain is also really cool because of their cannabis social clubs. I was lucky to spend a few weeks in Barcelona this fall. They have these incredible spaces that basically was like a mix between coffee shop, co-worker space, maybe a little bar worked in there — just like a community space where you can go and become a club member.
Also, keep an eye on Colombia. When Ismail and I, my colleague from the policy team, were at the UN, we spoke to the Colombian health minister about MDMA therapy. He said, “Yeah, that sounds really promising.” I’m optimistic about that. They’re kind of still in the process of reforming their drug policies, and though they haven’t made as dramatic of strides as the other countries, a lot of the ministers and people doing work in Colombia are a lot more conscious. They see all of the horrible impacts of the drug war on their country and want to improve it. I think they will continue to do this work and lead some reform in South America.
Then also of course Canada is leading the way in so many ways on the drug policy front. From legalizing cannabis to really strongly supporting harm-reduction measures in response to opiate crises. I think Canada is going to be the leader on drug policy reform, and probably on a lot of other policies as well.
Joe: What else is going on in your world? Are you projected a couple years out to be working on some other interesting projects, or what do you see happening?
Natalie: I can speak about something that’s really near to my heart. In context of MDMA-assisted psychotherapy for PTSD, we are working to develop a study that would be focused on racial trauma, or PTSD from racism. We are working on another focusing on PTSD in trans communities as well. I’m really interested in talking about how social injustice can manifest in an individual as PTSD. I think that’s going to be a really important conversation.
Anti-racist work within the psychedelic community is really important. A lot of people I know are these peace-loving, hippie types who have really beautiful ideals, but don’t necessarily know the details or the reality of certain situations. I’ve heard from so many amazing, well-intentioned people in this community, “I don’t see race. All people are the same.” I think the concept is beautiful and well-intentioned, but that’s also really ignoring the experience of people of color in this country.
Unfortunately, police officers do see race. Breaking that conversation open I think is immensely important. If we’re a community that really talks about healing and working in solidarity with other social justice movements, I think that is really essential. I have seen more and more progress on that front, but I just want to definitely flag that because I think we have a lot of room to improve in that space.
Joe: What does that look like to you? How could we heal a bit? I know the research itself is very white, really kind of bland, but in terms of diversity, how do we heal that? What do you see?
Natalie: Yes, the research is quite white, unfortunately. This study focusing on racial trauma, we’re working with Dr. Monica Williams in process, but she’s a leading researcher on PTSD from racism. Working with experts and therapists of color to do outreach to their own communities. We have to work with communities and not just go in and be like, “Why don’t you come into our space?” We have to be willing to meet people where they are and really listen, and hear what different communities need from us and how we can best work with them. I think really the best way, when you ask how can we heal, it’s really we as white, psychedelic enthusiasts need to do our own work We need to do our own reading and need to start asking questions. And not questions just of people of color, and asking them to do this emotional labor for us, but maybe other white people who are doing this work who might be able to help support this process.
It’s a really long, difficult process that requires a lot of self-reflection, which is why I think there’s so much potential in our psychedelic community.We’re a community so focused on being conscious and self-reflection. All of these things that are essential to understanding racial consciousness, and the impact of racism on white people. There’s a lot of hugely harmful impacts of racism in white people, the way that sexism deeply harms men in patriarchy. I think it’s really important that we are doing some of our own work. That is a difficult process but a healing one, The more conscious we are of things, I believe that is really a way to move towards healing.
Returning war veterans are incredibly traumatized and don’t have adequate support, but yet compared to someone living in a poor, black neighborhood in Atlanta … There was a study that returning war veterans had way lower rates of PTSD than people living in this community. These people are also underdiagnosed, and don’t have the resources that even… It’s just interesting context because certainly, we dramatically need to improve our support for veterans as well, but even just stepping back and seeing that there’s so many people suffering from PTSD who have no access, or no even language to understand what they’re going through.
Kyle: Do you have any last-minute advice for students or anyone that is interested in getting involved with policy work? Because now, maybe, with this fear of the new administration taking over, we don’t really know what the climate is going to look like.
Natalie: In this political climate, it’s more important than ever to do work also outside of the so-called direct political system. Advocacy even means talking to your family or friends, creating a cultural space to support this political work is the most important thing we can do. This ties back into the conversation about the whiteness and privilege of the psychedelic space. I totally understand that there are such a span of people who are able to speak openly about this in certain contexts. You can be at risk for losing your job, your children, and certainly people of color are far higher risk for being arrested for drugs or things like that. I think that’s a really powerful part of recognizing being conscious of your privilege in this community — if you feel safe enough to speak in certain communities and speak out, that it’s super-important to do that and use that privilege to move the conversation forward. There’s so many ways for people to get involved. MAPS alone has a million volunteer opportunities, or we’ll help you host a global psychedelic dinner if you want help inviting people in your community, and having things to talk about. I encourage people also to just think of whatever they’re most passionate about and do that, and see how psychedelics can intersect with that, and how they can speak in their space.
Check out the full audio interview with Natalie Ginsberg here.
Transcribed by: Rev.com
About Natalie Ginsberg
Natalie earned her Master’s in Social Work from Columbia University in 2014, and her Bachelor’s in History from Yale University in 2011. At Columbia, Natalie served as a Policy Fellow at the Drug Policy Alliance, where she helped legalize medical marijuana in her home state of New York, and worked to end New York’s racist marijuana arrests. Natalie has also worked as a court-mandated therapist for individuals arrested for prostitution and drug-related offenses, and as a middle school guidance counselor at an NYC public school. Natalie’s clinical work with trauma survivors spurred her interest in psychedelic-assisted therapy, which she believes can ease a wide variety of both mental and physical ailments by addressing the root cause of individuals’ difficulties, rather than their symptoms. Through her work at MAPS, Natalie advocates for research to provide evidence-based alternatives to both the war on drugs and the current mental health paradigm.
The future of psychedelic research is endless. There seems to be thousands of ways to get involved, and thousands of ways to approach the topic. In this talk, Kyle and Joe talk with Thomas Roberts Ph.D. — author of the book, The Psychedelic Future of the Mind: How Entheogens Are Enhancing Cognition, Boosting Intelligence, and Raising Values. Tom shares his story with us about how he got involved in the field of psychedelic research and education. Starting in 1981, Dr. Roberts taught one of the world’s first university-cataloged psychedelic course, “Foundations of Psychedelics Studies.”
We get into a great conversation with Tom about his early days at Esalen to talking about mindapps, mindbody states, and different ways to approach psychedelic research.
Topics of Discussion:
Esalen Institute — Stanislav Grof, Holotropic Breathwork, and Maslow
Psychedelics in humanities and religion
Joseph Campbell
How the, The Hero with a Thousand Faces relates to the new archetype of the conscious explorer
The Good Friday Experiment
Huston Smith
Tips and advice about starting a psychedelic course/independent study
Thomas B. Roberts promotes the legal adaptation of psychedelics for multidisciplinary cultural uses, primarily their academic and spiritual implications. He formulated Multistate Theory (2013) coined Singlestate Fallacy, mindapps, neurosingularity, metaintelligence, and ideagen, and he named and characterized the Entheogen Reformation (2016). He is a founding member of the Multidisciplinary Association for Psychedelic Studies, a cofounder of the Council on Spiritual Practices and the International Transpersonal Association, originated the Rising Researcher conference sessions, and launched the celebration of Bicycle Day to commemorate the day that Albert Hofmann first intentionally took LSD.
AB Hamilton College, MA University of Connecticut, PhD Stanford, Roberts is an emeritus professor of educational psychology at Northern Illinois University, where he taught Foundations of Psychedelic Studies as an Honors Program Seminar. Started in 1981 and taught through 2013, it is the world’s first university-cataloged psychedelic course.
In the fall of 2006, he was a Visiting Scientist at the Johns Hopkins Medical Schools’ Behavioral Pharmacology Research Unit (Griffiths psilocybin team). His website is: www.niu.academia.edu/ThomasRoberts
It is the start of a New Year. People are saying 2016 has been pretty horrible, but 2016 has been pretty decent in regards to psychedelic science and research. We are hoping that 2017 will be a fruitful year as well.
Download Joe and Kyle talk to Shannon Clare Petitt about the current state of MDMA research and what MAPS needs to do in the next number of months with the FDA as the phase three trials become approved. A few days after the interview the New York Times reported that the phase three research was approved. Shannon’s story is great and optimistic. If you are interested in how to get a job in the psychedelic field, this is certainly an episode you’ll want to listen to. We also discuss some possible tweaks to the studies that could be done that may yield interesting results, and also why MAPS is taking the approach that they are (its the most straightforward way to push the research through the FDA). Continue reading “Shannon Clare Petitt – MAPS, Zendo and an update on MDMA’s status”
Download Kyle recently had the great opportunity to attend one module of the MAPS MDMA Therapy sessions. In this episode we talk about the experience at the workshop and about some other valuable topics as well. Let us know what you think, and please leave a review on iTunes! Continue reading “Kyle and Joe – MAPS MDMA training in New York”
In this episode Kyle and Joe speak about the recent interview they recorded with Dimitri Muganis. There were some relatively important points in the interview that needed further discussion and expansion and in this podcast we unravel some of the material. There is plenty more to unpack there.
Some of what is discussed in this episode includes.
Race
Class
Research and Treatment
When should one take priority
Democratization of the medicines
Privilege
Paying for people to participate in research
The white upper middle class bias in the research
The bias in research towards veterans
Overall there are loads of things that we discussed, and in short the real message here is that we all need to keep moving forward. There is plenty of room for growth in the field for all of us to move our agendas forward.
With endless amounts of research left to be run, we can still treat people. I’m not sure we are going to see Psychedelic medicines be used in the next 1-2 years in major hospitals outside of research, but we are going to see it in the next decade for sure.
Neal M. Goldsmith, Ph.D. is a psychotherapist specializing in psychospiritual development. He is a popular speaker on drug policy reform, spiritual maturation, and the emergence of an integral society (a six-minute clip of his talk on the “Fusion of Spirit and Science” may be found at: http://vimeo.com/7517009) and an author, most recently of Psychedelic Healing: The Promise of Entheogens for Psychotherapy and Spiritual Development.
Dr. Goldsmith has curated dozens of successful conferences and cross-disciplinary “meetings of minds” for corporations as well as the psychedelic community, including the Horizons and MAPS Psychedelic Science conferences. He is a founder of several discussion salons on integral philosophy, governance, media, postmodern science, healing, and the future of society.
Bio via Psymposia – Katherine MacLean is an academically trained research scientist and meditation practitioner with a long-standing interest in the brain, consciousness and the science of well-being. As a graduate student at the University of California, Davis, Katherine was supported by a prestigious National Science Foundation research fellowship to study the effects of intensive meditation training on concentration, emotional well-being and brain function.
As a postdoctoral fellow and faculty member at the Johns Hopkins University School of Medicine, she was one of the only scientists in the world studying psilocybin — a psychedelic chemical found naturally in certain types of mushrooms. Her groundbreaking research on psilocybin and personality change suggests that psychedelic medicines may be the key to enhancing mental health and promoting openness and creativity throughout the lifespan.
Ingmar Gorman, M.A. is a currently unlicensed doctoral student in Clinical Psychology at the New School for Social Research. His clinical work is supervised by licensed clinical psychologists at his training sites. After receiving his B.A. in Psychology from the New College of Florida. Ingmar completed a pre-doctoral externship at Bellevue’s Chemical Dependency Outpatient Program and Dual Diagnosis Inpatient Unit, where he obtained specialized training in treating people living with substance use disorders. He has also gained extensive experience treating severe mental illness at South Beach Psychiatric Hospital’s Heights Hill Outpatient Clinic. Ingmar has trained in individual and group psychotherapy at Beth Israel Medical Center’s Psychiatric Inpatient Services, as well as the Brief Psychotherapy Research Program. Ingmar uses an integrative approach to treatment utilizing Cognitive Behavioral Therapy (CBT) and Psychodynamic principles. When treating substance misuse, Ingmar draws on his extensive training with Dr. Andrew Tatarsky and Dr. Jen Talley, in Harm Reduction Psychotherapy and Mindfulness based approaches.
Download
Lex, Kyle and Joe discuss MAPS, Psymposia, Ibogaine, Mushrooms, Ketamine, LSD, Cannabis, and loads more. Lex is working on a book related to the supremely complex neurochemistry of cannabis.